Literature DB >> 20015694

Suppressive influences of IFN-alpha on IL-17 expression in human CD4+ T cells.

Shunsei Hirohata1, Hideki Shibuya, Satoko Tejima.   

Abstract

We examined the direct effects of IFN-alpha on the development of Th17 with a system using immobilized anti-CD3, which permits activation of CD4+ T cells in the complete absence of accessory cells. Highly purified CD4+ T cells obtained from healthy donors were stimulated with immobilized anti-CD3 with or without IFN-alpha. IFN-alpha suppressed the production of IL-17 of immobilized anti-CD3-stimulated CD4+ T cells in a dose-response manner. Accordingly, IFN-alpha inhibited IL-17 mRNA expression in immobilized anti-CD3-stimulated CD4+ T cells. IFN-alpha did not affect the production of TGF-beta or IL-6, but inhibited RORC mRNA expression of anti-CD3-stimulated CD4+ T cells. These results indicate that IFN-alpha suppresses IL-17 expression and Th17 differentiation through down-regulation of RORC mRNA expression. It is therefore suggested that these effects might play a role in the mode of action of IFN-alpha in the treatment of various inflammatory diseases. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015694     DOI: 10.1016/j.clim.2009.11.012

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  3 in total

Review 1.  Cytokine regulation of B-cell migratory behavior favors formation of germinal centers in autoimmune disease.

Authors:  John D Mountz; John H Wang; Shutao Xie; Hui-Chen Hsu
Journal:  Discov Med       Date:  2011-01       Impact factor: 2.970

2.  IFN- alpha blocks IL-17 production by peripheral blood mononuclear cells in patients with chronic active hepatitis B Infection.

Authors:  Fang Cui; Jiangping Meng; Peng Luo; Pu Chen
Journal:  BMC Infect Dis       Date:  2014-02-01       Impact factor: 3.090

3.  A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients.

Authors:  Patricia López; Javier Rodríguez-Carrio; Luis Caminal-Montero; Lourdes Mozo; Ana Suárez
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.